All Access Articles |
- Intellia Therapeutics Reports Q4 2024 Financial Results | 2025-02-27 | BIOTECHNOLOGY
- Intellia Therapeutics Announces 2025 Milestones | 2025-01-10 | BIOTECHNOLOGY
- Intellia Therapeutics – Positive Phase 1 Data for Nexiguran Ziclumeran in ATTR-CM | 2024-11-18 | BIOTECHNOLOGY
- Intellia Therapeutics Rallies in Gene Editing Advancements | 2024-02-22 | BIOTECHNOLOGY